Rs 5,500 / VialGet Latest Price Product Details: Bremelanotide (PT-141) is an FDA-approved, centrally acting peptide used primarily to treat hypoactive sexual desire disorder (HSDD) in premenopausal women and, off-label, for erectile dysfunction/low libido in men
Handling Guidelines Proper handling procedures help maintain peptide integrity during laboratory preparation and storage
Baseline Health Assessment and Contraindication Screening Both platforms conduct medical evaluations to identify contraindications (personal or family history of medullary thyroid cancer, pancreatitis risk, renal impairment)
less than 1 percent of patients report dizziness, headache, or hyperactivity
and received research support from Merck
Ingredienti Edulcoranti (sciroppo di mal - titolo, eritritolo, xilitolo), gelificante (pectina), acidificante (acido citrico), L-carnitina-L-tar - trato, estratto di t verde [Camellia sinensis (L.) Kuntze) foglia, aroma naturale di agrumi con altri aromi naturali, citrato di zinco, aroma naturale, concentrato di carota e zucca, oli vegetali (cocco, colza), edulcorante (glicosidi steviolici da Stevia), agente di rivestimento (cera di carnauba), biotina (D-biotina), cloruro di cromo (III)
